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Background: Aortic aneurysm (AA) affects 15, 000 individuals in the United States and 
221,900 individuals in China die every year due to the dissection and rupture of an AA. 
Genetic disorders such as Marfan’s syndrome, increase the risk of developing AA. Our 
work seeks to identify novel molecular mechanisms that could become much needed 
therapeutic targets to prevent AA. We previously showed that the lysine deacetylase 
sirtuin-1 (SirT1) is crucial to protect the vascular wall against inflammatory and oxidant 
insults. We hypothesize that an increased oxidative stress in the vascular wall of patients 
with Marfan’s syndrome, inhibits SirT1 by oxidative post-translational modifications 
leading to vascular wall remodeling and AA.  
Methods:  To test our hypothesis we used fibrillin-1 mutant mice (Fbn1mgR/mgR), a genetic 
model of Marfan’s syndrome prone to AA, and wild type (WT) controls. Aortic sections 
or vascular smooth muscle cells (VSMC) homogenates from WT and Fbn1mgR/mgR were 
prepared and processed for dihydroethidium staining, NAD/NADH measurements and in-
gel zymography, respectively. In addition, we generated a mutant sirtuin-1 construct 
plasmid resistant to oxidative post-translational modifications as a novel tool to determine 
the role of sirtuin-1 in AA. 
Results: Our results indicate that there is an increase in oxidative stress and 
metalloproteinase activity in the thoracic aorta of Fbn1mgR/mgR compared to WT, while 
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NAD/NADH is not significantly increased. In addition, we successfully generated a mutant 
redox-resistant sirtuin-1 plasmid for future studies. 
Conclusion:  Our preliminary data strongly suggest that targeting oxidative stress and/or 
preventing oxidative post-translational modifications of SirT-1 represent a potential 
therapeutic avenue to prevent or ameliorate AA in patients as risk, such as those with 
Marfan’s syndrome. 
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An aortic aneurysm (AA) is a balloon-like bulge of the aorta, the artery that carries 
blood from the heart to the peripheral organs. This aortic dilatation may worsen into a tear 
between the layers of the aortic wall, known as aortic dissection, or rupture with bleeding 
inside the body [1]. Unfortunately, most AA are diagnosed after rupture, bringing the 
mortality up to 90% [1]. Approximately 15,000 individuals in the United States and 
221,900 individuals in China die every year of an AA dissection or rupture [1][2]. The first 
and most famous reported case of AA was King George II of Great Britain who succumbed 
to the disease in 1760 [3]. Since the 1950s, surgical repair was deployed as means of 
preventing the risk of AA dissecting or rupturing, while endovascular surgical repair, a less 
invasive technique, was implemented in the United States in 2005 [3]. Despite impressive 
research advances in our understanding of these deadly vascular diseases, surgical repair 
and anti-hypertensive medications remain the only treatment options currently approved. 
Therefore, there is an urgent need to identify novel therapeutic approaches to prevent 
deaths from AA dissections and ruptures. 
The vascular wall consists of an internal layer of endothelial cells (tunica intima), 
a middle layer comprising mainly of vascular smooth muscle (VSM) (tunica media), and 
an external layer called tunica adventitia. The tunica media can start degrading in response 
to increased wall tension, such as in patients with high blood pressure, or as a consequence 
of genetic disorders, such as Marfan’s syndrome. This degradation leads to uncontrolled 
dilatation of the vascular wall and further expansion to >50% of the initial diameter, which 
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is the definition of an AA [4][5]. If an aneurysmal dilatation furthers expands could 
eventually dissect or rupture, leading to intramural hemorrhage and blood accumulation 
within the thoracic or abdominal cavity, respectively, and death. Based on their location, 
aortic aneurysms are generally classified into thoracic and abdominal aneurysms. Thoracic 
aneurysms may involve one or more segments (aortic root, ascending aorta, arch, or 
descending aorta), and etiology differs for each segment. In contrast, abdominal aneurysms 
occur mainly in the infrarenal portions of the aorta and are more common in the elderly 
[4]. There are three types of aortic dissection depending on which aortic segment is mainly 
involved, according to Debakey classification: type I for the aortic arch, type II for the 
ascending arch, and type III for the descending aorta [4]. While aortic dissection is 
clinically manageable, aortic ruptures occur suddenly and often become fatal. 
The major risk factors for AA are high blood pressure, inflammation, smoking, a 
sedentary lifestyle, and genetic disorders such as Marfan’s, Loey-Dietz’s, and type 4 
Ehlers-Danlos’s syndromes. [5].  
Hypertension is one of the most common risk factors, present in over 2/3 of AA 
patients [6]. The accelerating effect of hypertension on aortic dilatations has been 
characterized in apolipoprotein E knockout (Apoe−/−) mice, an hyperlipidemic mouse 
model that develops abdominal aneurysms when infused with the hypertensive agent 
angiotensin II. However, the value of the Apoe−/− mouse model to study the human AA 
pathology remains debated since hypercholesterolemia is not a risk factor for AA in 
humans [6]. 
3 
Marfan’s syndrome (MS) is a genetic disorder affecting the connective tissue of the 
body, including the vasculature. MS patients are born with mutations in the fibrillin-1 gene 
[7] and they typically develop thoracic AA. Fibrillin-1 is a glycoprotein present in
extracellular elastin microfibrils of the medial layer of the aorta, the eyes, the skeleton. 
Robust evidence indicates that fibrillin-1 regulates the bioavailability of 
transforming growth factor beta (TGFβ), a cytokine important for cell survival, wound 
healing/fibrosis and metabolism [7]. TGFβ is present in the aortic as a small latent complex, 
which sequesters it in a non-active form. Specifically, the PF10 fragment of fibrillin-1 has 
been shown to bind to TGFβ and inactivates it. Therefore, in absence of fibrillin-1, such as 
in MS, TGFβ signaling is enhanced even though TGFβ expression levels are similar to 
healthy individuals [8][9]. 
Several human and animal studies indicate that TGFβ activity is significantly 
increased in aortas of MS because of genetically deficient fibrillin-1. There are two well-
characterized TGFβ signaling pathways [10]. In the canonical pathway, activation of the 
TGFβ receptor complex upon TGFβ binding phosphorylates Smad2/Smad3 and stimulates 
Smad4 nuclear translocation. This canonical signaling pathway has been associated with 
the development of thoracic AA [11]. For the noncanonical pathway, increased TGFβ 
activity leads to higher RNA and protein levels of matrix metalloproteinases (MMPs) 
through the extracellular signal-regulated (ERK)1/2 and p38 mitogen-activated protein 
kinases pathways [10]. Among the MMPs, MMP-2 and MMP-9 play pivotal roles in the 
degradation of the extracellular matrix in the aortic wall, leading to remodeling of the 
arterial wall which is also associated with AA. 
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Oxidative stress and AA 
Reactive oxygen and nitrogen species (RONS) are important signaling molecules 
which regulate cellular processes. However, the imbalance between an excessive 
production of RONS and cellular anti-oxidant defense systems, also known as oxidative 
stress, is the hallmark of various metabolic and vascular diseases including diabetes, 
atherosclerosis, high blood pressure and neurodegenerative disease [12]. However, the role 
of oxidative stress in the development of AA is only starting to emerge. 
There is some evidence that the pro-fibrotic cytokine TGFβ can promote oxidative 
stress by multiple ways [13]: (1) by stimulating mitochondrial complex IV activity; (2) by 
upregulating  NADPH oxidases (Nox) Nox 1, Nox2, and Nox4 expression levels likely via 
Smad, PI3K, MAP and RhoA/ROCK pathways; and (3) by suppressing the levels of 
cellular antioxidant defense mechanisms, such as glutathione (GSH). Human cells have 
multiple antioxidant systems, among which GSH and glutathione disulfide (GSSH) are the 
most abundant. GSH reduces ROS through glutathione peroxidase- (GPx) or glutathione 
reductase- (Grx) catalyzed reactions by being oxidized to GSSG. De novo GSH synthesis 
is a two-step reaction catalyzed by glutamate cysteine ligase (GCL), and GSH synthase 
(GS). TGF-β suppresses the expression levels of the GCL thereby decreasing GSH 
synthesis. [13]. Therefore, it is reasonable to postulate that in the vasculature of individuals 
with Marfan’s syndrome and related disorders, characterized by TGF-β activation, 
oxidative stress may play a role in the development of AA. 
A role of oxidative stress in the development of AA is also linked to the fact that 
increased oxidants are known to increase the activity of MMP-2 and MMP-9 in human 
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aortic vascular smooth muscle cells [14][15]. MMP-2 and MMP-9 play pivotal roles in the 
degradation of collagen and other extracellular matrix components in the aortic wall, 
leading to remodeling of the arterial wall, which is also associated with AA [10].  
Limited studies have been done to understand the relationship between oxidative 
stress and AA.  Jiménez-Altayó et al showed that ROS are important in the development 
of AA using Nox4-deficient Marfan mouse model (Fbn1mgR/mgR C1039G+/--Nox4-/-) [34]. 
However, this mouse model reproduces only one of the several mutations in fibrillin-1 gene 
found in Marfan’s patients therefore the generalization of these results are questionable. In 
a proteomic study, aortic segments obtained from 15 AA patients showed lower expression 
of the anti-oxidant enzyme superoxide dismutase than 10 control patients [31]. Similarly, 
Miller at al showed that there is increased oxidative stress in the abdominal AA segments 
compared to the adjacent non-aneurysmal aortic segments in patients with AA (n=12) [32]. 
Despite these findings are limited by the fact that there was no comparison with healthy 
controls, underscoring the difficulty of obtaining such control samples, still indicate a link 
between oxidants and AA.  
Current treatment options for AA are limited to surgical treatment and anti-
hypertensive drugs. The most commonly used anti-hypertensive drugs are β-blockers [34] 
and drugs that interfere with the renin-angiotensin system, namely angiotensin-II receptor 
blockers (ARBs) and angiotensin-converting enzyme inhibitors (ACEI), which are also 
very effective in decreasing blood pressure thereby decreasing the risk of AA dissection or 
rupture. However, despite some evidence that ARBs and ACEI may inhibit TGFβ signaling 
[17], their effectiveness in preventing or reducing aortic root growth is debated.  
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We hypothesize that decreasing oxidative stress could be a novel therapeutic 
approach to prevent AA.  
 
Sirtuin-1 and AA 
Sirtuin-1 (SirT1; mammalian homolog of silent information regulator in yeast) is a 
NAD+-dependent deacetylase and a molecular target of polyphenols and calorie restriction 
[18]. Our lab showed that SirT1 is generally associated with beneficial effects by virtue of 
antioxidant and anti-inflammatory effects on the aortic wall [19][20]. Specifically, we 
showed that SirT1 in vascular smooth muscle is required to maintain the structural integrity 
of the aortic wall in response to oxidant and inflammatory stimuli by suppressing oxidant-
induced matrix metalloproteinase activity [19].  
The relationship between SirT-1 and AA in Marfan’s syndrome is hardly known. 
In the Fbn1C1039G+/- Marfan mouse model, the SirT-1 agonist resveratrol inhibits aortic root 
dilatation [22]. Despite these promising results, resveratrol is known to have biological 
effects independent of SirT1 [29]. In addition, SirT-1 overexpression in the VSM cells has 
been shown to protect against, while VSM specific SirT1 ablation exacerbated, CaCl2-
induced AA, another model of AA. [33]. 
It is recognized that SirT-1 can be regulated by redox signaling. Bachschmid et al 
showed in vitro and in vivo that SirT-1 can be oxidatively modified on 3 cysteine residues 
nearby its catalytic site, inhibiting it deacetylase activity, in hepatocytes, where SirT-1 
oxidative inhibition contributes to fatty liver disease [23][35], However, whether SirT-1 
can be oxidized in the vascular smooth muscle cells and in the context of AA is unknown.
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 My goal was to understand the molecular mechanisms behind the development of 
AA in Marfan syndrome (MS). To this end, we employed fibrillin-1 knock out (Fbn1 
mgR/mgR) mice, a well-established model of MS prone to AA. We hypothesized that an 
excessive TGFβ activity, due to fibrillin-1 deficiency in MS, promotes oxidative stress in 
the thoracic aorta, and results in SirT1 oxidation and increased activity of MMPs, which 
lead to degradation of extracellular matrix and increasing the risk of developing AA and 






MATERIALS AND METHODS 
Dihydroethidium (DHE) (cat# D7008), was purchased from Sigma Aldrich. 
EnzyChrom™ NAD/NADH Assay Kit (cat# E2ND-100) was purchased from Fisher. 
Novex precast zymography gels (cat# ZY00100BOX), Novex™ Zymogram Renaturing 
Buffer (10X) (cat# LC2670), Novex™ Zymogram Developing Buffer (10X) (cat# 
LC2671), Novex™ Tris-Glycine SDS Sample Buffer (2X) (cat# LC2676 ) were 
purchased from Invitrogen. Coomassie Brilliant Blue R-250(cat# 161-0400) was 
purchased from Bio Rad. The following antibodies were used: anti-acetyl p53 (Cell 
Signaling), anti-total p53 (Novus) and anti-biotin antibody (Cell Signaling Technology), 
Tricine Protein Gels (ThermoFisher); streptavidin-agarose (cat # 20347) were purchased 
from ThermoFisher, and streptavidin magnetic beads were purchased from New England 
Biolaboratories. Custom-made biotin-labeled acetyl-lys382-p53 peptide with a 6-carbon 
linker (cat # 65045) and biotin-labeled acetyl-lys382-p53 peptide with a FLAG tag on its 
C-terminus were synthesized by Anaspec, San Jose, CA. 96-well dot blot apparatus was
purchased from Bio Rad.  QIAprep Spin Miniprep Kit (Cat# 27104) and QIAquick Gel 
Extraction Kit (Cat# 28704) were purchased from Qiagen. GoldHi EndoFree Plasmid 
Maxi Kit (Cat# CW2104S) was purchased from CWbio ( Kangwei Shiji). The PCR 
PrimeSTAR mastermix was purchased from Takeda (cat#R045Q). Sanger sequencing 
service, synthesis of PCR, and sequencing primers were obtained from Genewiz (South 
Plainfield, NJ, USA). Sequencing primers were as follows: CMV-F (5’- 
CGCAAATGGGCGGTAGGCGTG), T7 (5’-TAATACGACTCACTATAGGG), SP6 
(5’-GATTTAGGTGACACTATAG), forward SirT1 Sequencing Primer 2 Fwd (5’-
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AACATCTCATGATTGGCAC), and reverse SirT1 Sequencing Primer 1 Rev (5’-
ATGAACCAATTCCTTTTGTG),andF1-Ori-R (5’- 
AGGGAAGAAAGCGAAAGGAG). Site Directed Mutagenesis (SDM) PCR primers, 
designed to introduce C61S mutation in SirT1, were as follows (the targeted nucleotide is 
shown in red): forward primer C61S P2 Forward(5’-
GGCTCCGGCGGCCGCGGGGAGTGAGGCGGCGAGCGCCGC), and reverse primer 
C61S R Pim (5’-GGCGCTCGCCGCCTCACTCCCCGCGGCCGCCGGAG). 
Plasmid constructs pcDNA3.1_FLAG_HA_Sirtuin_1 expressing N-FLAG 
(DYKDDDDK)- and HA (YPYDVPDYA)-tagged murine wild type sirtuin1 (WT SirT1) 
cDNA (NM_019812.3) and  pcDNA3.1_FLAG_HA_Sirtuin_1_C318S_C613S with the two 
mutations C318S (C(TGT) to S(TCT)) and C613S (C(TGC) to S(TCC)) was a kind gift 
from Dr. Markus Bachschmid (Boston University School of Medicine). Both clones were 
verified by Sanger sequencing.  
Animal models 
All animal experimental procedures were approved by the institutional animal care 
and use (IACUC) committee at Boston University Medical Campus. Fbn1mgR/mgR mice 
were obtained from Dr Francisco Ramirez (Mount Sinai Medical College) [30]. 
Fbn1mgR/mgR carry an hypomorphic fibrillin-1 gene which results in severely decreased 
levels of fibrilin-1 protein, mimicking the genetic defect in Marfan’s syndrome; 
Fbn1mgR/mgR mice develop AA by 8 weeks of age and AA rupture within 12 weeks of age. 
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DHE staining and quantitation 
Dihydroethidium (DHE) is the reduced form of DNA-binding dye ethidium 
bromide. Due to its desirable quality of passively diffusing into cells, along with its high 
reactivity, DHE has been commonly used to detect nuclear and cytosolic superoxide and 
serves as a commonly used dye to detect reactive oxygen species (ROS) in cells and tissues 
[22]. While itself displaying a blue fluorescent signal, upon reaction with superoxide anion, 
DHE forms a red fluorescent product, 2-hydroxyethidium, intercalates into the DNA and 
exhibits a red fluorescence with an emission at 580nm [23] [24]. Despite its specific 
reaction to superoxide, DHE can also be oxidized unspecifically into ethidium by ONOO 
or •OH [25].  Despite these limitations, tissue DHE staining is a consistent and well-
established method to measure ROS, previously used in the Seta lab [19]. 
Aortas from WT (n=4) and Fbn1mgR/mgR (n=4) mice were carefully collected, 
segmented into ascending aorta, aortic arch, descending aorta and abdominal aorta and 
frozen in cutting medium OCT using liquid nitrogen. Twenty µm-thick aortic cryosections 
were prepared and kept at -20 degree Celsius until further analysis.  
On the day of DHE staining, sections were washed 3x with freshly prepared and 
ice-cold phosphate-buffered saline (PBS). DHE was freshly dissolved in DMSO, diluted 
into 50µM working solution in PBS and added to sections.  Sections were then incubated 
in a humidified chamber covered with aluminum foil at 37° C for 45 minutes. At the end 
of the incubation period, sections were washed 3x with PBS and glass cover-slipped with 
Prolong Gold Antifade mounting medium (Life Technologies). The slides were then stored 
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at -20° C and analyzed with an epifluorescent microscope within 48 hours (Nikon Eclipse 
80i).    
 Digital images were acquired at 40x magnification with laser filters in the FITC 
channel (to capture the autofluorescence of elastin lamellae in the aortic wall) and Texas 
Red channel (to capture the DHE positive signal). The post-acquisition image analysis was 
performed with ImageJ software (freely available at https://imagej.nih.gov/ij/ with 64-bit 
Java 1.8.0_112) in a blinded fashion, as the researcher performing the analysis was 
unaware of mice genotypes.   
 First, we performed background subtractions from both Texas Red and FITC 
channels using the “rolling ball background subtraction” feature, which can subtract 
background in an unbiased way. Thereafter, the FITC and Texas Red images of the same 
aorta segment were merged and converted to RGB color (8bits). The conversion allows to 
set a color threshold by which only red pixels, corresponding to DHE positive signal, are 
quantified. The image was further converted into a binary function for the final 
quantification. A region of interest (ROI) was selected to measure the area of the aortic 
segment. Then Integrated Density (IntDen) or RawInegrated Density (RawIntDen) were 
obtained after threshold settings on the binary function image, as shown in Figure 1. IntDen 
means (sum of pixel values in selection) * (area of one pixel), whereas RawIntDen means 
the sum of pixel values in the selection. We then normalized the RawIntDen and IntDen 
by the area of ROI, which indicates the amount of DHE fluorescence/area. Analysis of at 
least 4 aortic sections for each mouse were averaged before performing statistical analysis 




NAD/NADH ratio reflects the redox state of cells, including mitochondria’s 
function and, indirectly, the enzymatic activities of enzymes that require NAD or NADH 
as substrates, such as SirT1. Vascular Smooth Muscle Cells (VSMCs) were isolated from 
aortas of wild type (WT) and Marfan (Fbn1mgR/mgR) mice by enzymatic digestion and 
cultured on 6-well plates. Culture medium was replaced with fetal bovine serum (FBS)-
free Dulbecco's modified Eagle's medium (DMEM) for 4 hours before experiments. 
Rotenone (10µM, 5 minutes), a mitochondrion complex I inhibitor that prevents the 
conversion of NADH into NAD, was added as positive control for NADH detection.  
 Cells were collected using the extraction buffer from the EnzyChrom™ 
NAD/NADH Assay Kit. Cells were then sonicated and heated at 60 ° C for 5 minutes. The 
lysates were then centrifuged at 12,000 g for 10 minutes. 40 µl of the samples, standard 
curve and blank were then mixed with the reaction mix provided by the kit in a 96-well 
plate and the optical density (OD0 , time point “zero”) at 565 nm was read at room 
temperature with a plate reader. OD15 and OD30 were read after 15-min or 30-min 
incubation at room temperature. The calculation was done by first computing the ΔOD for 
each standard and sample by subtracting OD0 from OD15 or OD30. The slope of the standard 
curve was calculated and used to calculate the NAD(H) concentration of the samples with 
the following the equation (n represents dilution factor): 
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The NAD/NADH ratio for each sample was then calculated. Since the number of samples 
is below 7 and therefore non-parametric, Wilcoxon Signed-rank test were later performed 
by R software. 
 
In-gel zymography 
Vascular Smooth Muscle Cells (VSMCs) from WT and Fbn1mgR/mgR  mice were 
cultured in 1g/L (5.5 mM) glucose, FBS-free DMEM for 24 hours, in the presence or 
absence of  hydrogen peroxide (1mM ). Culture medium and cells were collected and 
homogenized with 200ul of lysis buffer (50 mmol/L Tris, 10 mmol/L CaCl2, 150 mmol/L 
NaCl, 1% Triton X-100, 0.1% SDS, 0.5% Brij 35, 0.05% azide pH 7.4) and centrifuged at 
16100 g for 15 minutes at 4oC to obtain the protein supernatant. Protein concentrations of 
cell lysates was determined with the BCA Protein Assay (Thermo Scientific) according to 
the manufacturer’s instructions. Equal amounts of cellular proteins (12µg) and 20 l 
culture medium were mixed with Novex™ Tris-Glycine SDS Sample Buffer (2X) and 
loaded on the Novex precast zymography gels. Protein separation was carried out in SDS-
containing running buffer for 4 hours at 4°C. The gels were then washed 3x in milli-Q 
water for 10 minutes, at room temperature to remove SDS. Gels were then soaked in 
Novex™ Zymogram Renaturing Buffer with gentle agitation for 30 minutes at room 
temperature, and with Novex™ Zymogram Developing Buffer for another 30 minutes at 
room temperature. After the second change of fresh development buffer, gels were 
incubated for 20 hours at 37oC. The gels were then rinsed with milli-Q water for 10 minutes 
and stained with 0.5% Coomassie Brilliant Blue R-250 dissolved in 40% methanol and 
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10% acetic acid for 1 hour with gentle agitation. Gels were then destained with 20% 
methanol and 5% acetic acid with gentle agitation for 1 minute. The image was captured 
by transillumination with a scanner (Perfection 4990 Photo; Epson) at 48-bit color and 720-
dpi resolution. White bright bands over a blue background are indicative of gelatin in-gel 
digestion by the enzymatic activity of MMPs. 
Generation of redox-resistant SirT-1 DNA plasmids 
With the assistance of Drs Markus Bachschmid and Vladimir Mastugin (Boston 
University School of Medicine, Vascular Biology Section), we designed a DNA plasmid 
(pcDNA3.1_FLAG_HA_Sirtuin_1_C318S_C613S_C61S) expressing a mutant form of 
SirT1 in which the three cysteine residues, C61, C318 and C613 are mutated into serine. 
Since cysteine thiol groups are replaced with similarly charged hydroxyl groups, these 3 
mutations are not expected to significantly affect SirT1 structure and activity, as previously 
reported [23]. We first generated plasmids expressing WT SirT1 and a double mutant SirT1 
isoform with C2987H/C2987I mutations, using a 5 Minute Transformation Protocol (New 
England bio lab). Briefly, streak plating was performed at 37C, overnight. The next day, 
colonies were selected and inoculated in a 4ml lysogeny broth (LB) medium overnight; 
plasmids were then extracted from the overnight culture using a QIAprep Spin Miniprep 
Kit. DNA concentrations were measured with a Nonodrop spectrophotometer and sent out 
for Sanger sequencing analysis to GeneWiz. The rest of the culture was transferred into a 
flask containing 150 ml LB medium and further cultured overnight. The next day, DNA 
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plasmids were extracted using GoldHi EndoFree Plasmid Maxi Kit according to 
manufacturer’s instructions.  
For the generation of the triple mutant SirT1 (C61S, C318S, C613S), we used the 
construct with double mutation (C613S, C318S) 
pcDNA3.1_FLAG_HA_Sirtuin_1_C318S_C613S as the template. The third point 
mutation, C61S (TGT to AGT) was introduced by Site Directed Mutagenesis (SDM) with 
some modifications. SDM is an in vitro procedure that uses custom-designed 
oligonucleotide primers to introduce a desired mutation in a double-stranded DNA 
plasmid [27].  A SDM primer (250pmol) (Supplementary figure 9) was first 5’-
phosphorylated by T4 Polynucleotide Kinase enzyme (20 U)(New England Biolabs, Cat# 
M0201S) and 1x T4 Ligase Buffer (New England Biolabs, Cat# M0202S) in a 20uL 
reaction volume for 30 min at 37C. PNK was then deactivated at 75C for 10min followed 
by a PCR reaction. The PCR reaction mixture was as follows: phosphorylated primers 
(15pmol), 2X PrimeSTAR max master mix (25µl), pcDNA-CMV-N-FLAG-HA-SIRT1-
(C318S)-(C613S)) (30ng) as template DNA and 3% DMSO. The following 
thermocycling conditions were used: 98 °C, 10 seconds; (98 °C, 10 seconds; 55 °C, 5 
seconds; 72 °C, 5 seconds) X 30 cycles, 72 °C, 1 minute. Dnpl (10U) was added to the 
PCR reaction mixture to degrade the parent strand for 15 minutes at 37o C.  The PCR 
DNA fragments were then mixed with T4 Ligase (400U) and NEB 10X T4 Ligase Buffer 
for 5 minutes at 25o C.  5µL of the ligation reaction, supposedly containing the triple 
mutant SirT1, was used to transform 50µL of NEB competent E.Coli cells (C2992) by 
incubating on ice for 30 minutes then heat-shocking for 30 seconds at 42 o C,  placing on 
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ice for further 5 minutes and finally plating onto ampicillin-containing plates 
(100µg/mL). After overnight incubation at 37C, colonies were selected from plates and 
inoculated in LB medium overnight. Plasmid was extracted with QIAprep Spin Miniprep 
Kit and GoldHi EndoFree Plasmid Maxi Kit, as described above. The triple mutation was 




We hypothesize that the increasing activity of TGFβ in aortic wall of individuals 
with Marfan’s syndrome increases oxidative stress, which contributes to the development 
of AA. We first measured the level of oxidative stress in vascular smooth muscle cells and 
aortic sections from WT and Fbn1mgR/mgR mice using two different approaches: (1) DHE 
staining, able to directly detect ROS, and (2) NAD/NADH ratio, which reflects mainly 
mitochondria complex function.  
 
DHE staining and quantitation 
 We found that levels of ROS measured by DHE staining in aortic segments of 
Fbn1mgR/mgR mice (n=4) were significantly increased compared to WT mice (n=4) (8.29 
5.345 in WT vs 19.46 7.035 in Fbn1mgR/mgR, p=0.047) (Figure 2). As shown in 
Supplemental Figures 1-2, sections from ascending aorta, aortic arch and descending aorta 
were the ones with the highest DHE positive staining, indicative of higher ROS, than 
segments of the abdominal aorta in Fbn1 mgR/mgR compared to WT mice.   
 
NAD/NADH assay 
 In contrast with DHE staining, although we observed a trend for NAD/NADH ratio 
towards lower levels in vascular smooth muscle cells (VSMCs) from Fbn1 mgR/mgR mice 
compared to WT, these changes in NAD/NADH ratio did not reach statistical significance 
(5.76  3.63 in WT vs 2.63 2.13 in Fbn1mgR/mgR , p= 0.2) (Figure 3). Interestingly, a 
detailed analysis of the data indicated that NAD/NADH ratio in Fbn1mgR/mgR VSMC is 
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comparable to WT VSMC treated with rotenone, a mitochondrial complex I inhibitor, 
suggesting that Fbn1mgR/mgR VSMC may experience mitochondrial dysfunction compared 
to WT VSMC. Further experiments will be necessary to obtain conclusive results. 
 
In-gel zymography 
Once established that levels of oxidants are elevated in Fbn1mgR/mgR VSMC 
compared to WT mice, we next tested the hypothesis that this increased oxidative stress is 
responsible for increased MMP activity in Fbn1mgR/mgR VSMC compared to WT. We 
assessed MMP activity using gelatin in-gel zymography, by optimizing previously 
described protocols. In gel zymography is a very sensitive technique for measuring the 
relative amounts of active gelatinases, mainly MMP-2 or MMP-9, in cells or tissues. We 
also used VSMCs treated with the reactive oxidant species hydrogen peroxide as positive 
control. 
Our preliminary results with n=1 show that MMP activity in the culture medium 
from Fbn1mgR/mgR VSMC and WT VSMC treated with hydrogen peroxide (1mM, 24 hours) 
was increased compared to the culture medium from WT VSMC controls (Figure 4). In 
contrast, this increase was not observed in cell homogenates. To note, MMP activity in 
Fbn1mgR/mgR VSM cells was higher than WT VSMCs treated with hydrogen peroxide 
suggesting the level of oxidant stress experienced by Fbn1mgR/mgR VSMC is substantial, 




Generation of redox-resistant SirT-1 DNA plasmids 
 SirT-1 is a redox sensitive NAD+-dependent deacetylase. Specifically, previous 
work showed that cysteine residues C61, C318 and C613, important for SirT-1 deacetylase 
activity, can be reversibly oxidized in a highly oxidative environment [23]. Our goal was 
to generate a DNA plasmid that expresses a mutant SirT-1 isoform resistant to oxidative 
post-translational modifications, thereby preserving its enzymatic activity. After several 
attempts and protocol optimization, Sanger sequencing confirmed that we successfully 
inserted the three desired mutations C318S (TCT), C613S (TCC) and C61S (GAG) (Figure 
5). In addition, we generated two nonsense mutations (A55 (GCG to GCT), A109 (GCC 
to GCT)) in a WT SirT-1 clone (Supplemental figure 4) that will be used as control in 
future experiments.  
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DISCUSSION 
Aortic aneurysm (AA) are deadly vascular conditions for which currently there are 
very limited treatment options. Our work seeks to identify novel therapies to prevent AA 
and associated risk of aortic wall dissection and rupture, leading to death.   
Previous work from the Seta’s lab [20] demonstrated that VSM SirT-1 is crucial to 
prevent aortic wall dissection in mice infused with angiotensin II by opposing 
inflammatory and oxidative processes, including MMP activation. SirT1 is a redox-
sensitive enzyme that can be oxidatively modified via carbonylation, S-nitrosylation, 
phosphorylation, S-glutathionylation and SUMOylation [28]. The former four 
modifications are believed to have an inhibitory effect on SirT-1 activity, whereas the latter 
has been shown to enhance SirT-1 activity.  
TGFβ activation is believed to contribute to the development of AA in individuals 
with Marfan’s syndrome (MS), a genetic disorder characterized by mutations in the 
fibrillin-1 gene. However, experimental and clinical approaches to blunt TGFβ remain 
controversial to prevent AA in Marfan’s patients so novel therapeutic approaches are 
urgently needed. 
TGFβ has been shown to increase oxidative stress in the aortic wall by multiple 
molecular mechanisms: (1) by interfering with mitochondrial complex activities [9]; (2) by 
stimulating the expression of ROS-generating enzymes NADPH oxidases Nox1, 2 and 4 
[9]; and (3) by decreasing the anti-oxidant enzymes such as glutamate-cysteine ligase 
(GCL) and GSH synthase (GS) [9]. Furthermore, it is well established that increased 
oxidants stimulate the activity of matrix-degrading enzymes MMPs, which are known to 
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contribute to aortic wall degradation during the development of AA. Therefore, we 
postulate that in Marfan’s syndrome, excess oxidants, possibly due to excessive TGFβ, 
may drive an impairment of SirT1 activity in the aortic wall leading to aortic wall 
remodeling and the development of AA. Therefore, preventing oxidative stress and/or 
oxidative inhibition of SirT1 activity may provide a novel therapeutic avenue to prevent 
AA.  
We discovered that aortas of a mouse model of Marfan syndrome (Fbn1mgR/mgR) 
have increased oxidants, as measured by DHE staining on aortic sections, compared to WT 
mice. We also detected a trend for NAD/NADH ratio, another index of cellular redox 
imbalance, to be decreased in VSM cells from Fbn1mgR/mgR mice compared to WT. This 
suggests that SirT1 activity in the aortic wall of Fbn1mgR/mgR mice could be inhibited by 
both oxidative post-translational modifications, due to excess oxidants, and by a decrease 
in available NAD+, which is an essential cofactor for SirT1 deacetylase activity. Ongoing 
studies are measuring levels of SirT1 oxidation and SirT1 activity in aortas and VSMC in 
WT and Fbn1mgR/mgR mice. 
To note, we observed that the increased DHE positive staining, indicative of ROS 
production, was present mainly in the thoracic aorta segments from Fbn1mgR/mgR mice, 
rather than the abdominal aorta. To the extent that this increase in oxidants is causally 
linked to the development of AA, this finding is in accordance with the fact that individuals 
with Marfan’s syndrome develop thoracic rather than abdominal AA. 
Furthermore, preliminary findings indicate that VSM cells from aortas of 
Fbn1mgR/mgR mice have increased MMP activity, as assessed by in gel zymography, 
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compared to WT VSMC suggesting that the increased oxidant production could stimulate 
MMP activity in Fbn1 mgR/mgR VSMC. MMP have been previously shown to greatly 
contribute to the development and progression of AA by degrading extracellular matrix in 
the aortic wall, leading to remodeling of the arterial wall [13].  
There are some limitations of this work. First, 4 WT and 4 Fbn1mgR/mgR mice were 
used for DHE staining therefore further experiments with more mice are warranted. 
Secondly, VSM primary cells used in our experiments are collected from the entire aorta. 
However, our data suggest that there are substantial molecular differences between the 
thoracic and abdominal aortas, at least in terms of ROS detected by DHE staining, 
therefore using VSM cells prepared from the entire aorta may not be fully reflective of in 
vivo processes. In the future, it would be interesting to have VSM cell preparations from 
different aortic segments and assess whether any molecular differences occur among 
them. Thirdly, we cannot rule out the contribution of gelatin-degrading enzymes other 
than MMP-2 and MMP-9, such as MMP-1 and MMP-3, to the signal observed in the in-
gel zymography. In addition, despite the newly generated plasmid expresses a triple 
mutant SirT-1 and this SirT1 isoform is resistant to oxidative post-translational 
modifications, low NAD/NADH levels in Marfan VSM cells could potentially still 
contribute to decreased SirT-1 activity. Lastly, our results on MMP activity are 
preliminary (n=1) and they will require more observations from more cell preparations. 
In terms of future direction, ongoing studies are optimizing an ELISA-based assay 
to accurately measure SirT-1 activity in VSM cells and aortic tissues to determine whether 
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SirT-1’s activity is decreased in thoracic aortas of patients and mice with Marfan’s 
syndrome due to reversible oxidation and low NAD/NADH ratio.   
It would also be interesting to assess whether treating Fbn1 mgR/mgR mice with a 
SirT-1 pharmacological activator or NAD+, to increase SirT1 activity, decreases MMPs 
activity and the incidence of AA. Moreover, we will also test whether overexpressing the 
triple mutant form of SirT1, which is resistant to oxidative inhibition, decreases MMP 
activity in Fbn1mgR/mgR VSM cells. To this end, I successfully generated a triple mutant 
SirT1 plasmid pcDNA3.1_FLAG_HA_Sirtuin_1_C318S_C613S_C61S, as confirmed by 
Sanger sequencing. However, further experiments are needed to confirm that the plasmid 
can be successfully transfected and translated in VSM cells, by measuring the levels of 
expression of FLAG, HA tags and SirT1 by Western blot, and whether it can prevent MMP 
activation in Fbn1mgR/mgR VSM cells. If these experiments prove successful, they will 
provide a valuable pre-clinical evidence for the translational application of the triple mutant 
SirT1 in the prevention of AA by using gene therapy. 
In conclusion, my work indicated an increased level of oxidants in aortas and 
vascular smooth muscle cells, which possibly stimulate MMP activity, in a mouse model 
of the Marfan’s syndrome compared to WT mice. The redox-resistant triple mutant SirT-1 
plasmid that I generated will be a valuable tool to further study the role of SirT-1 activity 
and the development of aortic aneurysm in Marfan’s syndrome and hopefully identify 
novel therapeutic approaches against these deadly vascular diseases. 
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FIGURES 
Figure 1. Illustration of steps for the analysis of DHE staining in aortic section 
using ImageJ.  
1. Area of the aorta was selected and measured in Texas Red channel. 2.
Background subtraction using rolling ball feature. 3. Merge of FITC and Texas Red
channels. 4. Adjustment of threshold to select pixels with DHE positive staining.
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Figure 2.  Quantitation of DHE positive staining in aortas of WT and Fbn1 
mgR/mgR mice. ROS were detected in aortic sections in WT (n=4) and Fbn1mgR/mgR 
(n=4) by DHE staining; data are normalized by area. *, p<0.05. mgR+/+ indicates 
Wild Type mice; mgR-/- indicates Fbn1mgR/mgR mice. Each dot represents the 
average of at least 4 aortic sections for each mouse. 
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Figure 3.  NAD/NADH ratio in wild type and Marfan VSMCs.  
NAD/NADH ratio measured in VSM cells cultured from WT and Fbn1mgR/mgR 
mice. mgR+/+ indicates Wild Type; mgR-/- indicates Fbn1mgR/mgR. Each dot 




















Figure 4. In-gel Zymography. 
Representative in-gel zymography indicative of metalloproteinase activities in culture 
medium and cell homogenate from VSMCs isolated from WT and Marfan mice. MMP, 
matrix metalloproteinase; WT, wild type; H2O2, hydrogen peroxide; kDa, kilodaltons; 
mgR-/-,Fbn1mgR/mgR. 
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 Figure 5.  partial DNA Sequence of pcDNA3.1_FLAG_HA_Sirtuin_1_C318S_C613S_ 
C61S;    introduced mutations shown in red. 
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SUPPLEMENTAL FIGURES 
S1. Representative images of aortic segments from a wild type (mgR+/+) mouse stained 
with DHE. 
1-3, thoracic aorta; 4-5 abdominal aorta; all images were taken at 40X magnification.
Autofluorescence of elastin fibers in the aortic wall are shown in green, DHE positive
pixels in red.
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S2. Representative pictures of aortic segments from a Fbn1mgR/mgR mouse stained with 
DHE. 
1-3, thoracic aorta; 4-5 abdominal aorta; all images were taken at 40X magnification.
Autofluorescence of elastin fibers in the aortic wall are shown in green, DHE positive
pixels in red.
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S3. DNA Sequence of pcDNA3.1_FLAG_HA_Sirtuin_1 Primers 
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 S4.  partial DNA Sequence ofpcDNA3.1_FLAG_HA_Sirtuin_1_C318S_C613S 
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